Investors place billion-dollar bets on AI “neolabs” without products
Research-first startups are raising large rounds before traditional product, revenue and customer signals exist.
TLDR
Investors are funding a class of research-first AI companies often called “neolabs” before they have public products or meaningful revenue. The Financial Times’ Lex column argues that headline valuations and financing figures can obscure how much of the money is committed in stages or tied to infrastructure and research milestones. The model can fund long-horizon discovery, but it leaves investors with fewer conventional signals such as customer demand, retention and margins.
Combined views
—
First seen 9h ago
Investors place billion-dollar bets on AI “neolabs” without products
Research-first startups are raising large rounds before traditional product, revenue and customer signals exist.
TLDR
Investors are funding a class of research-first AI companies often called “neolabs” before they have public products or meaningful revenue. The Financial Times’ Lex column argues that headline valuations and financing figures can obscure how much of the money is committed in stages or tied to infrastructure and research milestones. The model can fund long-horizon discovery, but it leaves investors with fewer conventional signals such as customer demand, retention and margins.
